Stratec SE Share Price
Stocks
SBS
DE000STRA555
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.40 EUR | -1.45% |
|
+9.76% | -7.80% |
| 15/07 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reaffirms its Neutral rating | ZD |
| 03/07 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg gives a Buy rating | ZD |
| Market Cap | 25Cr 29Cr 23Cr 22Cr 40Cr 2.74TCr 41Cr 277.99Cr 108.81Cr 1.36TCr 107.64Cr 105.32Cr 4.69TCr | P/E 2026 * |
20.1x | P/E 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise Value | 35Cr 40Cr 33Cr 30Cr 57Cr 3.83TCr 58Cr 389.12Cr 152.31Cr 1.9TCr 150.67Cr 147.42Cr 6.57TCr | EV / Sales 2026 * |
1.32x | EV / Sales 2027 * | 1.23x |
| Free-Float |
39.61% | Yield 2026 * |
3.24% | Yield 2027 * | 3.73% |
Last Transcript: Stratec SE
| 1 day | -1.45% | ||
| 1 week | +9.76% | ||
| Current month | +23.21% | ||
| 1 month | +16.95% | ||
| 3 months | +15.00% | ||
| 6 months | -8.41% | ||
| Current year | -7.80% |
| 1 week | 19 |  | 20.7 |
| 1 month | 16.7 | | 20.7 |
| Current year | 16.3 | | 24.5 |
| 1 year | 16.3 | | 33.1 |
| 3 years | 16.3 | | 52.4 |
| 5 years | 16.3 | | 147.4 |
| 10 years | 16.3 | | 147.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 59 | 01/04/2011 |
Tanja Bücherl
DFI | Director of Finance/CFO | 38 | 01/11/2025 |
Sandra Dittus
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Hiller
CHM | Chairman | 60 | 29/05/2019 |
Rolf Vornhagen
BRD | Director/Board Member | 73 | 21/07/2020 |
Georg Heni
CHM | Chairman | 68 | 20/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/03/23 | Buy | Chief Executive Officer | 150 | 0.0012% | ||
| 15/03/23 | Buy | Chief Executive Officer | 145 | 0.0012% | ||
| 13/03/23 | Buy | Chief Executive Officer | 220 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.45% | +9.76% | -29.59% | -59.01% | 29Cr | |
| +3.02% | +10.12% | +18.86% | +2.59% | 21TCr | |
| +1.30% | +11.19% | -1.92% | -23.46% | 14TCr | |
| +1.39% | +3.35% | -26.75% | +10.80% | 13TCr | |
| +1.21% | +6.65% | -56.48% | -10.89% | 6.85TCr | |
| +0.77% | -1.03% | +6.61% | -0.07% | 4.82TCr | |
| -0.04% | +4.09% | -24.96% | -31.74% | 4.56TCr | |
| +1.92% | +5.78% | +17.57% | +11.50% | 3.97TCr | |
| +3.42% | +4.45% | +26.97% | +34.34% | 3.77TCr | |
| +2.90% | +6.72% | -23.60% | -6.37% | 3.01TCr | |
| Average | +1.44% | +5.04% | -9.33% | -7.23% | 7.52TCr | |
| Weighted average by Cap. | +1.88% | +5.29% | -4.44% | -2.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27Cr 30Cr 25Cr 23Cr 43Cr 2.91TCr 44Cr 295.11Cr 115.51Cr 1.44TCr 114.27Cr 111.8Cr 4.98TCr | 28Cr 32Cr 26Cr 24Cr 46Cr 3.09TCr 46Cr 313.61Cr 122.75Cr 1.53TCr 121.43Cr 118.81Cr 5.29TCr |
| Net income | 1.4Cr 1.6Cr 1.31Cr 1.2Cr 2.25Cr 152.65Cr 2.29Cr 15Cr 6.06Cr 76Cr 6Cr 5.87Cr 261.56Cr | 1.83Cr 2.08Cr 1.7Cr 1.57Cr 2.94Cr 199.06Cr 2.99Cr 20Cr 7.91Cr 99Cr 7.82Cr 7.65Cr 341.08Cr |
| Net Debt | 10Cr 11Cr 9.37Cr 8.62Cr 16Cr 1.1TCr 16Cr 111.13Cr 43Cr 543.09Cr 43Cr 42Cr 1.88TCr | 9.77Cr 11Cr 9.1Cr 8.37Cr 16Cr 1.06TCr 16Cr 107.93Cr 42Cr 527.45Cr 42Cr 41Cr 1.82TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | €20.70 | +3.24% | 4,218 |
| 27/26/27 | €20.05 | +1.78% | 6,241 |
| 24/26/24 | €19.70 | +1.76% | 4,823 |
| 23/26/23 | €19.36 | +0.83% | 11,406 |
| 22/26/22 | €19.20 | +1.80% | 3,969 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SBS Stock
Select your edition
All financial news and data tailored to specific country editions
